Helicobacter macacaeMazF interplays with Escherichia coli homologs and enhances antibiotic tolerance.
- Published in:
- Helicobacter, 2023, v. 28, n. 5, p. 1, doi. 10.1111/hel.13014
- By:
- Publication type:
- Article
Works matching IS 10834389 AND DT 2023 AND VI 28 AND IP 5
Results: 13
1
2
Research trends on vonoprazan‐based therapy for Helicobacter pylori eradication: A bibliometric analysis from 2015 to 2023.
- Published in:
- Helicobacter, 2023, v. 28, n. 5, p. 1, doi. 10.1111/hel.13012
- By:
- Publication type:
- Article
3
Association of Helicobacter pylori with migraine headaches and the effects of this infection and its eradication on the migraine characteristics in adults: A comprehensive systematic review and meta‐analysis.
- Published in:
- Helicobacter, 2023, v. 28, n. 5, p. 1, doi. 10.1111/hel.13010
- By:
- Publication type:
- Article
4
Antibiotic resistance and heteroresistance in Helicobacter pylori isolates from symptomatic Vietnamese children: A prospective multicenter study.
- Published in:
- Helicobacter, 2023, v. 28, n. 5, p. 1, doi. 10.1111/hel.13009
- By:
- Publication type:
- Article
5
Genome‐wide association study of Helicobacter pylori serological status in Latin American children.
- Published in:
- Helicobacter, 2023, v. 28, n. 5, p. 1, doi. 10.1111/hel.13008
- By:
- Publication type:
- Article
6
TikTok and Bilibili as sources of information on Helicobacter pylori in China: A content and quality analysis.
- Published in:
- Helicobacter, 2023, v. 28, n. 5, p. 1, doi. 10.1111/hel.13007
- By:
- Publication type:
- Article
7
Issue Information.
- Published in:
- Helicobacter, 2023, v. 28, n. 5, p. 1, doi. 10.1111/hel.12905
- Publication type:
- Article
8
Antibiotic resistance, heteroresistance, and eradication success of Helicobacter pylori infection in children.
- Published in:
- Helicobacter, 2023, v. 28, n. 5, p. 1, doi. 10.1111/hel.13006
- By:
- Publication type:
- Article
9
Antimicrobial screening involving Helicobacter pylori of nano‐therapeutic compounds based on the amoxicillin antibiotic drug.
- Published in:
- Helicobacter, 2023, v. 28, n. 5, p. 1, doi. 10.1111/hel.13004
- By:
- Publication type:
- Article
10
Efficacy and safety of vonoprazan‐based dual therapy and esomeprazole‐based dual therapy in eradicating primary Helicobacter pylori infection: A propensity score matching analysis.
- Published in:
- Helicobacter, 2023, v. 28, n. 5, p. 1, doi. 10.1111/hel.13003
- By:
- Publication type:
- Article
11
Association between genetic polymorphisms of NOD1, Interleukin‐1B, and cagA strain with low‐grade duodenal eosinophilia in Helicobacter pylori‐related dyspepsia.
- Published in:
- Helicobacter, 2023, v. 28, n. 5, p. 1, doi. 10.1111/hel.13002
- By:
- Publication type:
- Article
12
Helicobacter hepaticus promotes liver fibrosis through oxidative stress induced by hydrogenase in BALB/c mice.
- Published in:
- Helicobacter, 2023, v. 28, n. 5, p. 1, doi. 10.1111/hel.13001
- By:
- Publication type:
- Article
13
Helicobacter pylori induces urease subunit B‐specific CD8<sup>+</sup> T cell responses in infected individuals via cytosolic pathway of cross‐presentation.
- Published in:
- Helicobacter, 2023, v. 28, n. 5, p. 1, doi. 10.1111/hel.13005
- By:
- Publication type:
- Article